POLA PENGGUNAAN ANTIBIOTIK PADA PASIEN PNEUMONIA RAWAT INAP DI RSUD dr. GONDO SUWARNO TAHUN 2021
Abstract
Pneumonia is an infection at the ends of the bronchioles and alveoli which causes acute inflammation of the lung parenchyma caused by various pathogens such as bacteria, fungi, viruses and parasites. Most are caused by bacteria. Inappropriate use of antibiotics can lead to increased resistance, wasted costs and does not achieve optimal clinical benefits in the prevention and treatment of infections and bacterial resistance to drugs. The purpose of this study was to determine the suitability of the use of antibiotics according to therapy with the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines. This research method is a type of descriptive non-experimental research with a retrospective approach using cross sectional. Data collection according to the prescription of inpatients at dr. Gondo Suwarno who received antibiotics. Then grouped by type of antibiotic, dose, class, and duration of antibiotic administration. The number of samples is 100. Then the data is adjusted between therapy and guidelines. Based on the results of the study, it was found that there were more male patients. The most widely used dosage form is injection. The most common class of antibiotics is the cephalosporin group. In CAP pneumonia, the number of patients was 46 with the accuracy of the type of drug levofloxacin as many as 12 (26.08%). In HAP pneumonia, the number of patients was 54, with the accuracy of the type of antibiotic levofloxacin in 16 (29.62%). The…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.